DD MEDICALL: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DD MEDICALL
Largest movements
- Cash -€80
no longer reported in 2025 (was €80)
mainly Trade debts (-€4,361) and Net result for the year (-€2,499)
- Other debts +€6,715
up €6,715 (+98.5%), from €6,816 to €13,531
- Trade debts -€4,361
down €4,361 (-91.9%), from €4,743 to €382
- Profit (loss) carried forward -€2,499
down €2,499 (-3.6%), from -€70,319 to -€72,818
- Short-term financial debts +€65
new in 2025: €65
- Gross operating margin -€7,756
down €7,756, from €5,965 to -€1,791
- Financial charges -€904
down €904 (-82.8%), from €1,092 to €188
- Other operating charges +€132
up €132 (+34.2%), from €387 to €520
- Financial income -€93
no longer reported in 2025 (was €93)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €80 | - | -€80 | |
| Current assets | 29/58 | €80 | - | -€80 | |
| Cash at bank and in hand | 54/58 | €80 | - | -€80 | |
| Total equity and liabilities | 10/49 | €80 | - | -€80 | |
| Equity | 10/15 | -€11,480 | -€13,978 | -€2,499 | -21.8% |
| Contributions | 10/11 | €58,600 | €58,600 | = | 0.0% |
| Reserves | 13 | €240 | €240 | = | 0.0% |
| Non-distributable reserves | 130/1 | €240 | €240 | = | 0.0% |
| Reserves not available under the articles | 1311 | €240 | €240 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€70,319 | -€72,818 | -€2,499 | -3.6% |
| Amounts payable | 17/49 | €11,560 | €13,978 | +€2,419 | +20.9% |
| Amounts payable within one year | 42/48 | €11,560 | €13,978 | +€2,419 | +20.9% |
| Financial debts | 43 | - | €65 | +€65 | |
| Credit institutions | 430/8 | - | €65 | +€65 | |
| Trade debts | 44 | €4,743 | €382 | -€4,361 | -91.9% |
| Suppliers | 440/4 | €4,743 | €382 | -€4,361 | -91.9% |
| Other amounts payable | 47/48 | €6,816 | €13,531 | +€6,715 | +98.5% |
| Other operating charges | 640/8 | €387 | €520 | +€132 | +34.2% |
| Gross operating margin | 9900 | €5,965 | -€1,791 | -€7,756 | |
| Operating profit (loss) | 9901 | €5,578 | -€2,310 | -€7,888 | |
| Financial income | 75/76B | €93 | - | -€93 | |
| Recurring financial income | 75 | €93 | - | -€93 | |
| Financial charges | 65/66B | €1,092 | €188 | -€904 | -82.8% |
| Recurring financial charges | 65 | €1,092 | €188 | -€904 | -82.8% |
| Profit (loss) for the period before taxes | 9903 | €4,579 | -€2,499 | -€7,078 | |
| Profit (loss) for the period | 9904 | €4,579 | -€2,499 | -€7,078 | |
| Profit (loss) for the period to be appropriated | 9905 | €4,579 | -€2,499 | -€7,078 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.